apollo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
  1. Home
  2. Medicine

  3. Intiflo 0.75mg/100ml Injection

Intiflo 0.75mg/100ml Injection, Pack of 1 Injection
Intiflo 0.75mg/100ml Injection, Pack of 1 Injection
Intiflo 0.75mg/100ml Injection, Pack of 1 Injection
Intiflo 0.75mg/100ml Injection, Pack of 1 Injection
Intiflo 0.75mg/100ml Injection, Pack of 1 Injection
Offers on medicine orders
All offers
axis icici
Written By Lakshmithulasi Yarragunta ,
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD

Intiflo 0.75mg/100ml Injection is used to treat Myocardial Infarction and Acute Coronary Syndrome. It contains Eptifibatide, which belongs to the monoclonal anti-glycoprotein IIb/IIIa receptor antibodies class. It works by blocking the glycoprotein IIb/IIIa receptor's activity, thereby preventing platelet aggregation. This inhibits fibrinogen binding, reducing the chance of blood clot formation. Intiflo 0.75mg/100ml Injection reduces the risk of cardiovascular events like myocardial infarction (heart attack).

Read more
rxMedicinePrescription drug

Whats That

tooltip

Also Explore

Momverse
Ask Apollo
insurance

Composition :

EPTIFIBATIDE-0.75MG

Manufacturer/Marketer :

Cipla Ltd

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

Expires on or after :

About Intiflo 0.75mg/100ml Injection

Intiflo 0.75mg/100ml Injection belongs to the group of medicines called 'antiplatelet agents' used to prevent the formation of blood clots, thereby reducing the chance of Myocardial infarction. Intiflo 0.75mg/100ml Injection is used in the treatment of Acute coronary syndrome (ACS) in both patients who need to be managed medically and also people undergoing percutaneous coronary intervention (PCI) procedures. ACS is defined as a group of serious cardiac conditions wherein the blood flow to the heart decreases due to plaque formation. Intiflo 0.75mg/100ml Injection is also used in the treatment of patients undergoing urgent PCI procedures and also in patients undergoing intracoronary stenting.

Intiflo 0.75mg/100ml Injection contains Eptifibatide, which belongs to the monoclonal anti-glycoprotein IIb/IIIa receptor antibodies class. It works by blocking the glycoprotein IIb/IIIa receptor's activity, thereby preventing platelet aggregation. This causes inhibition of fibrinogen binding, reducing the chance of blood clot formation. Intiflo 0.75mg/100ml Injection reduces the risk of cardiovascular events like myocardial infarction (heart attack).

Intiflo 0.75mg/100ml Injection may cause certain side effects, such as bleeding, nausea, headache, abdominal pain, hypotension, vomiting, dizziness, decreased platelet count, and pain at the site of injection. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor. A trained healthcare professional will administer Intiflo 0.75mg/100ml Injection. So, do not self-administer. Your doctor will decide the dose of the medicine based on your health condition.

Intiflo 0.75mg/100ml Injection should be avoided if you are allergic to it. It is contraindicated in patients who have active internal bleeding, history of bleeding diathesis within 30 days, thrombocytopenia, severe uncontrolled hypertension, had recent major surgery or trauma, renal failure, using another glycoprotein IIb/IIIa inhibitor, a history of cerebrovascular accident within the last two years, or recent gastrointestinal or genitourinary bleeding, intracranial neoplasm, aneurysm, as it can cause serious adverse effects. Intiflo 0.75mg/100ml Injection is known to cause bleeding problems. If you observe severe bleeding that cannot be controlled, it is advised to stop administering Intiflo 0.75mg/100ml Injection immediately. Hence, close monitoring is needed for any bleeding conditions. Talk to your doctor before receiving Intiflo 0.75mg/100ml Injection if you had a recent severe injury or surgery due to the risk of severe bleeding problems. If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor before taking Intiflo 0.75mg/100ml Injection. Intiflo 0.75mg/100ml Injection is not recommended for children below 12 years of age as efficacy and safety have not been established.

Uses of Intiflo 0.75mg/100ml Injection

Intiflo 0.75mg/100ml Injection is used to prevent heart attacks in high-risk patients. The detailed uses of Intiflo 0.75mg/100ml Injection are as follows:<br/>• Prevents early myocardial infarction: Intiflo 0.75mg/100ml Injection is used for unstable angina or non-Q-wave myocardial infarction, especially within 24 hours of chest pain.<br/>• Recommended for high-risk patients: Intiflo 0.75mg/100ml Injection is beneficial for those with ECG changes, elevated cardiac enzymes, or those likely to undergo early PTCA.<br/>

Directions for Use

• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.• Intiflo 0.75mg/100ml Injection will be administered in the hospital setting by a trained healthcare professional.• Do not self-administer.

Medicinal Benefits

Intiflo 0.75mg/100ml Injection contains Eptifibatide, which belongs to the monoclonal anti-glycoprotein IIb/IIIa receptor antibodies class. It works by blocking the glycoprotein IIb/IIIa receptor's activity, thereby preventing platelet aggregation. This causes inhibition of fibrinogen binding, reducing the chance of blood clot formation. Intiflo 0.75mg/100ml Injection results in reducing the risk of cardiovascular events like myocardial infarction (heart attack) and other cardiac events.

How Intiflo 0.75mg/100ml Injection Works

Intiflo 0.75mg/100ml Injection contains Eptifibatide, which belongs to the monoclonal anti-glycoprotein IIb/IIIa receptor antibodies class. It works by blocking the glycoprotein IIb/IIIa receptor's activity, thereby preventing platelet aggregation. This causes inhibition of fibrinogen binding, reducing the chance of blood clot formation. Intiflo 0.75mg/100ml Injection reduces the risk of cardiovascular events like myocardial infarction (heart attack).

Storage

• Store in a cool and dry place away from sunlight.
• Keep Intiflo 0.75mg/100ml Injection out of the sight and reach of children.
• Cold chain - To be stored in cold places at 2ºC to 8ºC.
Side effects of Intiflo 0.75mg/100ml Injection
Managing Low Blood Pressure Triggered by Medication: Expert Advice:
  • If you experience low blood pressure symptoms like dizziness, lightheadedness, or fainting while taking medication, seek immediate medical attention.
  • Make lifestyle modifications and adjust your medication regimen under medical guidance to manage low blood pressure.
  • As your doctor advises, regularly check your blood pressure at home. Record your readings to detect any changes and share them with your doctor.
  • Fluid intake plays a vital role in managing blood pressure by maintaining blood volume, regulating blood pressure, and supporting blood vessel function. Drinking enough fluids helps prevent dehydration, maintain electrolyte balance, and regulate fluid balance.
  • Take regular breaks to sit or lie down if you need to stand for long periods.
  • When lying down, elevate your head with extra pillows to help improve blood flow.
  • Avoid heavy exercise or strenuous activities that can worsen low blood pressure.
  • Wear compression socks as your doctor advises to enhance blood flow, reduce oedema, and control blood pressure.
  • If symptoms persist or worsen, or if you have concerns about your condition, seek medical attention for personalized guidance and care.
  • Managing a low platelet count (thrombocytopenia) caused by medication usage requires a multi-step approach. Here are some steps to help manage the condition:
  • Inform your doctor about your low platelet count and medication usage. They will assess the situation and guide the best course of action.
  • Your doctor may recommend adjusting or stopping the medication that is causing a low platelet count. This could involve switching to alternative medication or reducing the dosage.
  • Monitor your platelet count regularly through blood tests to track any changes. This will help the doctor determine the effectiveness of the treatment plan.
  • If an underlying condition, such as infection or inflammation, contributes to the low platelet count, your doctor will treat it.
  • In some cases, alternative treatments like platelet transfusions or medications that stimulate platelet production may be necessary.
  • Avoid risky activities and certain medications; eat a balanced diet with plenty of water to reduce bleeding risk and boost overall health.
  • If you experience severe bleeding or bruising, seek emergency medical attention immediately.

What if I have taken an overdose of Intiflo 0.75mg/100ml Injection

As Intiflo 0.75mg/100ml Injection is a parenteral formulation administered by experienced medical staff, the chance of overdose may be less. If you think there has been an overdose or experiencing any adverse events, get medical care right away. In a medical setting, an overdose would be treated quickly.

Drug Warnings

Do not receive Intiflo 0.75mg/100ml Injection if you are allergic to it. It is contraindicated in patients who have active internal bleeding, history of bleeding diathesis within 30 days, thrombocytopenia, severe uncontrolled hypertension, had recent major surgery or trauma, renal failure, using another glycoprotein IIb/IIIa inhibitor, a history of cerebrovascular accident within the last two years, or recent gastrointestinal or genitourinary bleeding, intracranial neoplasm, aneurysm, as it can cause serious adverse effects. Intiflo 0.75mg/100ml Injection is known to cause bleeding problems. However, if you observe severe bleeding that cannot be controlled, it is advised to stop administering Intiflo 0.75mg/100ml Injection immediately. Hence, close monitoring of patients is needed for any bleeding conditions. Talk to your doctor before receiving Intiflo 0.75mg/100ml Injection if you had a recent severe injury or surgery due to the risk of severe bleeding problems. Before taking Intiflo 0.75mg/100ml Injection inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding due to serious foetal harm. Intiflo 0.75mg/100ml Injection is not recommended for children below 12 years of age as efficacy and safety have not been established. Talk to your doctor before receiving Intiflo 0.75mg/100ml Injection if you have/had a recent severe injury or surgery due to the risk of severe bleeding problems.

Drug-Drug Interactions

verifiedApollotooltip
EptifibatideProtamine
Critical
EptifibatidePrasugrel
Severe

Drug-Drug Interactions

Login/Sign Up

EptifibatideProtamine
Critical
How does the drug interact with Intiflo 0.75mg/100ml Injection:
Coadministration of protamine and Intiflo 0.75mg/100ml Injection may increase the risk of bleeding

How to manage the interaction:
Taking Intiflo 0.75mg/100ml Injection with Protamine is not recommended, they can be taken together if prescribed by a doctor. However, if you experience any unusual symptoms contact your doctor immediately. Do not stop using any medications without first talking to your doctor.
EptifibatidePrasugrel
Severe
How does the drug interact with Intiflo 0.75mg/100ml Injection:
Co-administration of Intiflo 0.75mg/100ml Injection with Prasugrel can increase the risk of bleeding.

How to manage the interaction:
Co-administration of Prasugrel with Intiflo 0.75mg/100ml Injection can possibly result in an interaction, but it can be taken if a doctor has advised it. However, if you experience unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult the doctor. Do not stop using any medications without a doctor's advice.
EptifibatideIbrutinib
Severe
How does the drug interact with Intiflo 0.75mg/100ml Injection:
Co-administration of Ibrutinib with Intiflo 0.75mg/100ml Injection can increase the risk of bleeding.

How to manage the interaction:
Taking Ibrutinib with Intiflo 0.75mg/100ml Injection together can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult a doctor. Do not stop using any medications without a doctor's advice.
EptifibatideApixaban
Severe
How does the drug interact with Intiflo 0.75mg/100ml Injection:
Coadministration of Intiflo 0.75mg/100ml Injection and Apixaban co-administration may raise the risk of bleeding.

How to manage the interaction:
Even though combining Intiflo 0.75mg/100ml Injection and Apixaban may cause an interaction, it is still possible to take it if your doctor advises you to. Consult a doctor if you experience symptoms like blood in your urine or stool (or a black stool), severe bruising, prolonged nosebleeds, feeling dizzy or lightheaded, weakness or severe headache, vomiting blood or coughing up blood, heavy menstrual bleeding (in women), difficulty breathing, or chest pain. Without consulting a doctor, never stop taking any medications.
EptifibatideDabigatran etexilate
Severe
How does the drug interact with Intiflo 0.75mg/100ml Injection:
Taking Dabigatran etexilate with Intiflo 0.75mg/100ml Injection can increase the risk of bleeding leading to serious blood loss.

How to manage the interaction:
Taking Dabigatran etexilate with Intiflo 0.75mg/100ml Injection together can possibly result in an interaction, but it can be taken if your doctor has advised it. However, if you experience unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult the doctor. Do not stop using any medications without a doctor's advice.

Drug-Food Interactions

verifiedApollotooltip
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Drug-Food Interactions

Login/Sign Up

Diet & Lifestyle Advise

  • Eat a diet rich in whole grains, vegetables, fruits, skinless poultry, fish, eggs, and low-fat dairy products.
  • Avoid smoking and alcohol consumption.
  • Maintain a healthy weight with proper diet and exercise.
  • Managing stress with meditation, yoga, and massage.
  • Avoid eating fried food, fast food, boxed food, canned food, and processed frozen meals.

Habit Forming

No

Therapeutic Class

ANTIFIBRINOLYTIC AGENTS

Intiflo 0.75mg/100ml Injection Substitute

Substitutes safety advice

Product Substitutes

bannner image

Alcohol

Unsafe

Alcohol intake might increase the risk of stomach or intestine bleeding. Hence, avoid alcohol consumption. Consult your doctor for more information.

bannner image

Pregnancy

Unsafe

It is not recommended for use in pregnancy as it may harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Intiflo 0.75mg/100ml Injection. Your doctor may prescribe this medicine if the benefits outweigh the risks.

bannner image

Breast Feeding

Unsafe

It is not recommended for use in breastfeeding as it may pass into breast milk and harm your infant. Hence, if you are breastfeeding, inform your doctor before receiving Intiflo 0.75mg/100ml Injection. Your doctor may suggest you stop feeding while on treatment with this medicine.

bannner image

Driving

Not applicable

Intiflo 0.75mg/100ml Injection is used in PCI procedures in a hospital setting. Driving is not recommended.

bannner image

Liver

Caution

If you have liver problems, inform your doctor beforehand.

bannner image

Kidney

Caution

If you have kidney impairment, inform your doctor beforehand. Intiflo 0.75mg/100ml Injection is not recommended for use in patients with renal toxicity.

bannner image

Children

Unsafe

Intiflo 0.75mg/100ml Injection is not recommended for use in children below 12 years of age, as efficacy and safety have not been established.

Have a query?

FAQs

Intiflo 0.75mg/100ml Injection is used to treat Myocardial Infraction and Acute Coronary Syndrome.

Intiflo 0.75mg/100ml Injection contains Eptifibatide (anti-glycoprotein IIb/IIIa receptor), which works by blocking the glycoprotein IIb/IIIa receptor&#039;s activity, thereby preventing platelet aggregation. This causes inhibition of fibrinogen binding, reducing the chance of blood clot formation.

Intiflo 0.75mg/100ml Injection is known to increase the risk of bleeding. However, if the patient has uncontrollable bleeding, discontinue the medicine immediately.

Intiflo 0.75mg/100ml Injection may cause anaemia (low haemoglobin and low red blood cell count). So, it would be best to include iron-rich food in your diet to prevent anaemia.

Country of origin

India

Manufacturer/Marketer address

Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
Other Info - INT0070

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
icon image

Keep Refrigerated. Do not freeze.Prepaid payment required.

Author Details

Dr Aneela SiddabathuniDoctor badge

Reviewed By

Dr Aneela Siddabathuni

MPharma., PhD

Last Updated

Jul 18, 2025 | 9:22 AM IST

Doctor imageWe provide you with authentic, trustworthy and relevant information

Reference

  1. https://www.ncbi.nlm.nih.gov/books/NBK541066/
  2. https://go.drugbank.com/drugs/DB00063
  3. https://reference.medscape.com/drug/integrilin-eptifibatide-342149#4
  4. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020718s037lbl.pdf
  5. https://www.rxlist.com/integrilin-drug.htm

Buy best Cardiology products by

whatsapp Floating Button